Automated Insulin Delivery in Older Adults: Why Time in Range Alone Isn't the Whole Story
New research challenges the assumption that maximizing time in range should be the primary goal for all older adults using automated insulin delivery systems. Experts say individual health factors matter just as much.
Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.
Key takeaways
- Automated insulin delivery systems can improve time in range for older adults with Type 1 diabetes, but higher time in range doesn't automatically mean better health outcomes for everyone
- Goals for blood sugar management should be personalized based on each person's age, overall health, and life circumstances—not based on a single metric
- Healthcare teams working with older adults need to consider quality of life, risk of low blood sugar, and individual preferences alongside glucose targets
What the Research Shows
A new study published in the Journal of Diabetes Science and Technology examined how automated insulin delivery systems work for older adults living with Type 1 diabetes. While these systems are effective at keeping blood sugar in target range more often, the research raises an important question: Is maximizing time in range the right goal for everyone?
The findings suggest the answer isn't straightforward. Older adults have different health needs, different levels of independence, and different priorities than younger people. What works best for one person may not be ideal for another, even if both have Type 1 diabetes.
Time in Range Isn't Everything
Time in range—the percentage of time blood sugar stays within a target zone—is an important measure of diabetes management. But it's not the only measure that matters. For older adults, other factors can be equally or even more important.
Reducing the risk of low blood sugar, maintaining energy and mental clarity, avoiding frequent alarms and notifications, and fitting treatment into daily life all matter. A system that keeps someone in range 90% of the time but causes constant worry or disruption might not be better than one that achieves 85% time in range while giving someone peace of mind.
Personalization Is Key
The research underscores an important principle: diabetes management goals should be tailored to each person. For some older adults, the highest possible time in range makes sense. For others, a slightly lower target might be more appropriate if it means fewer lows, less stress, or better quality of life.
Healthcare providers working with older adults using automated insulin delivery should discuss what matters most to each person. This conversation should include questions about fear of low blood sugar, comfort with technology, daily routines, and how much time someone wants to spend thinking about diabetes management.
Moving Forward
As automated insulin delivery systems become more available and more advanced, the research suggests that success shouldn't be measured by a single number. Instead, it should reflect whether the system helps each older adult live well with Type 1 diabetes in a way that works for their unique situation.
If you or an older adult you care for uses or is considering an automated insulin delivery system, talking with your healthcare team about what 'good control' means for your specific circumstances is an important step.
Evidence label
Source: Journal of diabetes science and technology. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Related reading
More evidence-labeled coverage across the Type1Cure library.
- Living With T1DWhat We're Learning About Diabetic Ketoacidosis in Type 1 Diabetes: A French StudyPubMed indexed literature
- Living With T1DCorrection to "The Use of an Automated Insulin Delivery System Is Associated With a Reduction in Diabetes Distress and Improvement in Quality of Life in People With Type 1 Diabetes".PubMed indexed literature
- Living With T1DA New Class of Biologics Could Change How We Treat Type 1 DiabetesPubMed indexed literature
- Living With T1DMenopause and Type 1 Diabetes: What Women Need to KnowPubMed indexed literature
- Living With T1DThe Promise and Challenge of Oral Insulin: Where the Research StandsPubMed indexed literature
- Living With T1DYour Glucose Range May Not Be the Guideline Range—And That's Worth UnderstandingPubMed indexed literature